Objectives-To report on the extent and nature of acute MDMA (ecstasy) related problems presenting to a large London hospital's accident and emergency (A&E) department. Method-The computerised attendance records for all patients attending the A&E department over a 15 month period were retrospectively screened. Potential cases thus identified had their case notes systematically reviewed to confirm the history of MDMA use and to extract other relevant data. Results-Forty eight consecutive MDMA related cases were identified. All were in the 15-30 year age group with the majority presenting in the early hours at weekends and having consumed the drug at a night club. The mean number of tablets consumed was two and almost 40% had taken MDMA before. Polydrug use was common with half of the sample having concurrently taken another illicit substancemost commonly other stimulants (amphetamines and cocaine). A wide range of adverse clinical features was found. The most common symptoms were vague and non-specific such as feeling strange or unwell, however many patients had collapsed or lost consciousness. The most common signs elicited were related to sympathetic overactivity, agitation/ disturbed behaviour, and increased temperature. The more serious complications of delirium, seizures, and profound unconsciousness (coma) were commoner when MDMA was used in combination with other substances. Conclusions-For young adults presenting late at night at weekends and exhibiting symptoms of sympathetic overactivity, disturbed behaviour, and increased temperature ("Saturday night fever") the use of stimulant dance drugs especially MDMA should be suspected. As MDMA use does not appear to occur in isolation, the clinical picture is likely to be complicated by multiple rather than single drug ingestion. This poses increased diagnostic and management challenges for A&E staff who typically represent the front line response to dance drug related problems. (JAccid Emerg Med 1998;15:322-326) 
Ecstasy, the street name for 3,4, methylenedioxymethamphetamine (MDMA) is a modified synthetic amphetamine reported to have both stimulant and hallucinogenic properties.' Anecdotal accounts and media reports suggest it is used by up to 500 000 people at weekends in the UK,2 while scientific surveys have reported that 6-9% of young people have tried MDMA.3 While adverse complications have been described in association with its use,' 6 the true incidence of these reactions is not known. Ghodse et al have demonstrated that accident and emergency (A&E) departments are well placed to provide information about drug misuse,7 8 a point underscored in a recent Department of Health report,9 which highlighted the potential of A&E departments in collecting data on illicit drug use. Descriptions in the literature of the adverse effects of MDMA use in humans have to date been provided predominantly by single or small series case reports (for review see Thomasius et The present study represents a novel large series of consecutive cases of MDMA related problems presenting to a single inner city A&E department. It reports on symptoms described by patients at the time of presentation (that is immediately after the adverse experience) and describes the "at first hand " clinical observations of medical and nursing staff. panic, and psychosis). This list of possible "identifiers" was reached after discussion with A&E staff and from our review of the complications of MDMA use described in the literature. However, the more extended list did not help identify any more cases than did restricting the search to the five reasons for attendance given above. The A&E department of St Thomas' Hospital serves a resident catchment population of approximately 150 000 but there is in addition a significant non-resident population (commuters, tourists, and homeless people) which is likely to double this figure. No abnormal clinical findings were elicited in The most commonly reported symptom three cases. In one case certain clinical features group included non-specific complaints such (namely testicular pain and scrotal swelling) as: feeling strange, unwell, dizzy, or weak (15; were deemed coincidental with rather than as a 31.3%). The next most common complaints direct consequence of MDMA use. were collapse or loss of consciousness (11; In view of the fact that two thirds (n=32/48) 22.9%), nausea/vomiting (11; 22.9%), and of the sample reported concurrent consumppalpitations (10; 20.8%). Psychiatric symp-tion of either other illicit drug(s) and/or toms such as anxiety, panic, and restlessness alcohol, we separated out those cases (n= 16/ were also frequently reported (11, 22.9%). In 48) where only MDMA use was reported 17 cases (35%) at least two out of these five (tables 3 and 4). Symptom reports were similar complaints were reported. Symptoms possibly in both groups except that complaints of related to temperature control (for example collapse or loss of consciousness were less frefeeling excessively hot, cold, feverish, or shiver-quent in the MDMA only group (6.3% v ing ) occurred in seven (15%) cases.
Method
31.1 %). With regard to clinical signs, hyperOn clinical examination the most commonly ventilation (37.5% v 12.5%) and increased elicited signs included increased pulse rate (32; temperature (31.5% v 12.5%) were more 66.6%), dilated pupils (18; 37.5%), tachyp-common, and increased blood pressure (0% v noea (10; 20.8%), and raised body tempera-18.8%) less common in those using MDMA ture (nine; 18.8%). Anxiety, agitation, or only, otherwise there was little to distinguish disturbed behaviour was also commonly found the two subgroups. Numbers were too small to (10; 20.8%). In 12 cases (25.0%) at least three allow any meaningful statistical comparisons. out of these five clinical signs were elicited at The more serious complications, however, presentation.
occurred exclusively in the polydrug group. By classifying adverse effects as mild, moderate, or severe according to the scheme adopted MANAGEMENT AND DISPOSAL (TABLE 5) by the National Poisons Information Service,'5 After initial assessment, 41 (85.4%) cases had we found that only in six episodes were they an electrocardiogram or continuous cardiac severe. These more serious complications monitoring. In 30 cases (62.5%) the patient included delirium (confusion/disorientation) received a further period of observation and The majority of MDMA related episodes seem to have been managed effectively in the A&E department and most patients were safely discharged home after a variable period of time. In most cases minimal interventions (cardiac monitoring, clinical observation, and reassurance) were all that was necessary. Indeed 17% were discharged immediately after initial assessment. This is not to minimise the potential for more serious complications which can occur with this drug.5 Fluids were administered in almost a third of cases, probably reflecting concerns about dehydration and thermoregulatory problems known to occur in association with MDMA. Furthermore, admission was deemed necessary for seven individuals and one patient required full resuscitation in the A&E department. The one in five patients refused treatment is worrying with no further information available as to how these patients fared. Although advice, presumably about the dangers of drug use, was recorded to have been given in 29% of cases, referral to or provision of information on specific drug agencies was rare.
Our subgroup of MDMA users who presented to an A&E department with drug related problems cannot, of course, easily be generalised to the greater population of MDMA users who may or may not use this drug without complication. However, in a large community sample of stimulant users it was reported that up to a fifth did experience an adverse experience with MDMA." The retrospective nature of our study meant reliance on data recorded in medical and nursing notes. Nevertheless we found a high level of consistency in data recording and much information was collected in a standard fashion (for example medical history taking and description of clinical findings). An additional limitation was that drug use was not confirmed by urine toxicology. Although routine urinalysis in A&E departments has been proposed by some authors,'9 results are unlikely to influence the acute management given the time delay involved.
In conclusion, A&E departments can provide a unique opportunity to monitor, manage, and perhaps prevent substance misuse problems. For young adults presenting late at night at weekends and exhibiting symptoms of sympathetic overactivity, disturbed behaviour, and increased temperature ("Saturday night fever") the use of stimulant dance drugs especially MDMA should be suspected. As MDMA use does not appear to occur in isolation, the clinical picture is likely to be complicated by multiple rather than single drug ingestion. This poses increased diagnostic and management challenges for A&E staff who typically represent the front line response to dance drug related problems.
